Rare diseases
Investigational molecules
Locations
Study on Sibeprenlimab for Patients with IgA Nephropathy
ItalyStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
ItalyStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
ItalyStudy on Ertugliflozin for Children and Teens with Type 2 Diabetes
ItalyStudy of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma
ItalyStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
ItalyStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
ItalyStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
ItalyStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
ItalyStudy of Pembrolizumab for Patients with Advanced Solid Tumors
ItalyStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
ItalyStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
